Related Experiment Video
Updated: Apr 7, 2026

High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry
Published on: September 23, 2014
Differential Tissue-Specific Function of Adora2b in Cardioprotection
Seong-wook Seo1, Michael Koeppen2, Stephanie Bonney3
1Department of Anesthesiology, University of Colorado Denver, Aurora, CO 80045; Department of Biochemistry and Molecular Biology, School of Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea;
Adenosine A2b receptor (Adora2b) signaling protects the heart from injury. Its role differs based on cell type, with endothelial and myocyte Adora2b mediating preconditioning, while inflammatory cell Adora2b is key for ischemia/reperfusion injury.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Immunology
Background:
- Adenosine A2b receptor (Adora2b) is known to play a role in cardioprotection against myocardial ischemia.
- The specific tissue in which Adora2b exerts its cardioprotective effects remains unclear.
- Understanding tissue-specific roles is crucial for developing targeted therapies for myocardial ischemia.
Purpose of the Study:
- To investigate the tissue-specific functions of Adora2b signaling in cardioprotection during myocardial ischemia.
- To differentiate the roles of Adora2b in endothelial cells, myocytes, and inflammatory cells.
- To elucidate the mechanisms underlying Adora2b-mediated protection in different cardiac injury models.
Main Methods:
- Generation of tissue-specific Adora2b knockout mice (floxed Adora2b crossed with Lyz2-Cre, VE-cadherin-Cre, or myosin-Cre mice).
- Induction of myocardial ischemia/reperfusion (IR) injury with or without ischemic preconditioning (IP).
- Assessment of infarct size, troponin levels, and cytokine profiles; adoptive transfer of neutrophils.
Main Results:
- IP-mediated cardioprotection was abolished in mice lacking Adora2b in endothelial cells or myocytes.
- Cardioprotection against IR injury was impaired in mice lacking Adora2b in inflammatory cells (Lyz2-Cre mice).
- Polymorphonuclear neutrophils (PMNs) were identified as a key cell type expressing Adora2b for IR injury protection.
Conclusions:
- Adora2b signaling mediates distinct cardioprotective mechanisms in a tissue-specific manner.
- Endothelial and myocyte Adora2b are critical for ischemic preconditioning.
- Adora2b on inflammatory cells, particularly PMNs, is essential for protection against ischemia/reperfusion injury.
Related Concept Videos
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy

